Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.
TLDR
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.
- V. Mazzaferro, J. Llovet, P. Majno
- MedicineThe Lancet. Oncology
- 2009
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.
TLDR
The genetic determinants of the CYP3A5 polymorphism.
- E. Hustert, M. Haberl, L. Wojnowski
- Biology, MedicinePharmacogenetics
- 1 December 2001
TLDR
Extended resections for hilar cholangiocarcinoma.
- P. Neuhaus, S. Jonas, R. Hintze
- MedicineAnnals of surgery
- 1 December 1999
TLDR
Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.
- H. Oettle, P. Neuhaus, H. Riess
- MedicineJAMA
- 9 October 2013
TLDR
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).
- R. Adam, V. Karam, A. Burroughs
- MedicineJournal of hepatology
- 1 September 2012
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis
- S. Jonas, W. Bechstein, P. Neuhaus
- MedicineHepatology
- 1 May 2001
TLDR
Sex is a major determinant of CYP3A4 expression in human liver
- R. Wolbold, K. Klein, U. Zanger
- Biology, MedicineHepatology
- 1 October 2003
TLDR
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study
- R. Adam, V. Cailliez, H. Bismuth
- MedicineThe Lancet
- 19 August 2000
...
1
2
3
4
5
...